摘要
分析了新药研发中的管理期权,结合案例用二叉树模型计算了新药研发中的放弃期权和推迟期权价值,指出应从模型参数设定检验、研发成本波动性、其它竞争性新药信息收集、期权的最优执行等方面加强新药研发中的期权价值管理,并得出结论:二叉树模型是新药研发价值管理的有用工具。
Options nested in R＆D of new medicine were analyzed.Values of abandonment option and deferral option were calculated with binomial model in a case study.The measures of verification of model parameters specification,R＆D cost volatility,the information gathering of competing new medicine,and optimal exercise of options should be taken to manage option value.Binominal model is a helpful value management tool for R＆D of new medicine.
出处
《科技进步与对策》
CSSCI
北大核心
2007年第9期74-77,共4页
Science & Technology Progress and Policy
